JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, D. R.
Right arrow Articles by Bishop, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, D. R.
Right arrow Articles by Bishop, D. A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 934-941, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Degeneration of aortic valve allografts in young recipients

DR Clarke, DN Campbell, AR Hayward and DA Bishop
Childrens Hospital, Denver, Colo. 80218.

Aortic allograft fibrocalcification and valvular insufficiency have been observed in patients less than 3 years of age at initial replacement of the left ventricular outflow tract. From June 1985 through May 1992, 47 children have undergone aortic root replacement with cryopreserved aortic valve allografts. Thirty-three children were 3 years of age or older and 14 were less than 3 years of age at operation. In the older patient group, there were three (9%) hospital deaths and one child underwent cardiac transplantation 30 hours after aortic root replacement because of left ventricular failure. Clinical follow-up of the 29 surviving older children is from 4 months to 6.6 years (mean 3.0 years). One patient was lost to follow-up. Two children (7%) have required reoperation, but primary allograft degeneration was not observed. In the younger patient group, there were three (21%) hospital deaths. Follow-up ranged from 2.5 months to 4.7 years (mean 2.3 years). Among 11 operative survivors, one late death resulted from a pulmonary embolus. Seven of 10 (70%) remaining allograft recipients had progressive allograft calcification or insufficiency. Six of them have required reoperation to explant the allograft, and one child is currently receiving cyclosporine therapy with the original valve allograft. The cause of allograft failure is possibly immunologic. The prevalence of early aortic valve allograft degeneration has prompted the consideration of nonviable allografts or xenografts, pulmonary autografts, or minimal immunosuppression as alternatives when left ventricular outflow tract reconstruction is necessary in children less than 3 years of age.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
G. Amir, X. Ma, V. M. Reddy, F. L. Hanley, O. Reinhartz, C. Ramamoorthy, and R. K. Riemer
Dynamics of human myocardial progenitor cell populations in the neonatal period.
Ann. Thorac. Surg., October 1, 2008; 86(4): 1311 - 1319.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. A. Bacha, D. B. McElhinney, K. J. Guleserian, S. D. Colan, R. A. Jonas, P. J. del Nido, and G. R. Marx
Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: Acute and intermediate effects on aortic valve function and left ventricular dimensions
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 552 - 559.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. D. Stewart, C. L. Backer, N. D. Hillman, C. Lundt, and C. Mavroudis
The Ross Operation in Children: Effects of Aortic Annuloplasty
Ann. Thorac. Surg., October 1, 2007; 84(4): 1326 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Sierra, J. T. Christenson, N. H. Lahlaidi, M. Beghetti, and A. Kalangos
Right Ventricular Outflow Tract Reconstruction: What Conduit to Use? Homograft or Contegra?
Ann. Thorac. Surg., August 1, 2007; 84(2): 606 - 611.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Schmidtke, G. Dahmen, and H.-H. Sievers
Subcoronary Ross Procedure in Patients With Active Endocarditis
Ann. Thorac. Surg., January 1, 2007; 83(1): 36 - 39.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Chiappini, C. Barrea, and J. Rubay
Right Ventricular Outflow Tract Reconstruction With Contegra Monocuspid Transannular Patch in Tetralogy of Fallot
Ann. Thorac. Surg., January 1, 2007; 83(1): 185 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Karamlou, E. H. Blackstone, J. A. Hawkins, M. L. Jacobs, K. R. Kanter, J. W. Brown, C. Mavroudis, C. A. Caldarone, W. G. Williams, B. W. McCrindle, et al.
Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 829 - 838.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Shetty, A Pepin, A Charest, J Perron, D Doyle, P Voisine, F Dagenais, P Pibarot, and P Mathieu
Expression of bone-regulatory proteins in human valve allografts
Heart, September 1, 2006; 92(9): 1303 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. B. Luciani, A. Favaro, G. Casali, F. Santini, and A. Mazzucco
Ross Operation in the Young: A Ten-Year Experience
Ann. Thorac. Surg., December 1, 2005; 80(6): 2271 - 2277.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Karamlou, K. Jang, W. G. Williams, C. A. Caldarone, G. Van Arsdell, J. G. Coles, and B. W. McCrindle
Outcomes and Associated Risk Factors for Aortic Valve Replacement in 160 Children: A Competing-Risks Analysis
Circulation, November 29, 2005; 112(22): 3462 - 3469.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Z. Tavakkol, S. Gelehrter, C. S. Goldberg, E. L. Bove, E. J. Devaney, and R. G. Ohye
Superior Durability of Synergraft Pulmonary Allografts Compared With Standard Cryopreserved Allografts
Ann. Thorac. Surg., November 1, 2005; 80(5): 1610 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. W. Brown, M. Ruzmetov, M. D. Rodefeld, P. Vijay, and M. W. Turrentine
Right Ventricular Outflow Tract Reconstruction With an Allograft Conduit in Non-Ross Patients: Risk Factors for Allograft Dysfunction and Failure
Ann. Thorac. Surg., August 1, 2005; 80(2): 655 - 664.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Karamlou, R. M. Ungerleider, B. Alsoufi, G. Burch, M. Silberbach, M. Reller, and I. Shen
Oversizing pulmonary homograft conduits does not significantly decrease allograft failure in children
Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 548 - 553.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J.-M. Grinda, J.-L. Mainardi, N. D'Attellis, M.-O. Bricourt, A. Berrebi, J.-N. Fabiani, and A. Deloche
Cryopreserved Aortic Viable Homograft for Active Aortic Endocarditis
Ann. Thorac. Surg., March 1, 2005; 79(3): 767 - 771.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. K. Hooper, J. A. Hawkins, T. C. Fuller, T. Profaizer, and R. E. Shaddy
Panel-Reactive Antibodies Late After Allograft Implantation in Children
Ann. Thorac. Surg., February 1, 2005; 79(2): 641 - 644.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Ketchedjian, P. Kreuger, H. Lukoff, E. Robinson, A. Linthurst-Jones, K. Crouch, L. Wolfinbarger, and R. Hopkins
Ovine panel reactive antibody assay of HLA responsivity to allograft bioengineered vascular scaffolds
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 159 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ali, B. Iung, E. Lansac, P. Bruneval, and C. Acar
Homograft replacement of the mitral valve: Eight-year results
J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. E. Shaddy, T. C. Fuller, J. B. Anderson, L. M. Lambert, M. K. Brinkman, T. Profaizer, and J. A. Hawkins
Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation
Ann. Thorac. Surg., May 1, 2004; 77(5): 1734 - 1739.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. T. Christenson, D. Vala, J. Sierra, M. Beghetti, and A. Kalangos
Blood group incompatibility and accelerated homograft fibrocalcifications
J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 242 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. W. Grauss, M. G. Hazekamp, S. van Vliet, A. C. Gittenberger-de Groot, and M. C. DeRuiter
Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. G. Hogan and M. F. O'Brien
Improving the allograft valve: does the immune response matter?
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1251 - 1253.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. F. Baskett, M. A. Nanton, A. E. Warren, and D. B. Ross
Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 232 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Hawkins, N. D. Hillman, L. M. Lambert, J. Jones, G. B. Di Russo, T. Profaizer, T. C. Fuller, L. L. Minich, R. V. Williams, and R. E. Shaddy
Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 247 - 252.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Chauvaud, T. Waldmann, N. d'Attellis, P. Bruneval, C. Acar, J. Gerota, M. Jarraya, and A. Carpentier
Homograft replacement of the mitral valve in young recipients: mid-term results
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 560 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. R. Koolbergen, M. G. Hazekamp, E. de Heer, E. F. Bruggemans, H. A. Huysmans, R. A. E. Dion, and J. A. Bruijn
The pathology of fresh and cryopreserved homograft heart valves: An analysis of forty explanted homograft valves
J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 689 - 697.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. E. Shaddy and J. A. Hawkins
Immunology and failure of valved allografts in children
Ann. Thorac. Surg., October 1, 2002; 74(4): 1271 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. B. Mitchell, D. N. Campbell, D. A. Bishop, T. Mackenzie, and D. R. Clarke
Surgical options and results of repeated aortic root replacement for failed aortic allografts placed in childhood
J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 459 - 470.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Breymann, W.-R. Thies, D. Boethig, R. Goerg, U. Blanz, and R. Koerfer
Bovine valved venous xenografts for RVOT reconstruction: results after 71 implantations
Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 703 - 710.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Simon-Kupilik, J. Bialy, R. Moidl, M.-T. Kasimir, M. Mittlbock, G. Seebacher, E. Wolner, and P. Simon
Dilatation of the autograft root after the Ross operation
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 470 - 473.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z. Al-Halees, F. Pieters, F. Qadoura, M. Shahid, M. Al-Amri, and F. Al-Fadley
The Ross procedure is the procedure of choice for congenital aortic valve disease
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. C. Landis, G. Asimakopoulos, M. Poullis, D. O. Haskard, and K. M. Taylor
The antithrombotic and antiinflammatory mechanisms of action of aprotinin
Ann. Thorac. Surg., December 1, 2001; 72(6): 2169 - 2175.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. C. Landis, D. O. Haskard, and K. M. Taylor
New antiinflammatory and platelet-preserving effects of aprotinin
Ann. Thorac. Surg., November 1, 2001; 72(5): S1808 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
Y. J. Kim, Y. S. Choi, J. R. Lee, and J. R. Rho
Ventricular Outflow Tract Reconstruction With Polystan Valved Conduit
Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 187 - 191.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Mavroudis and C. L. Backer
Surgical management of severe truncal insufficiency: experience with truncal valve remodeling techniques
Ann. Thorac. Surg., August 1, 2001; 72(2): 396 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J.-F. Legare, D. B. Ross, T. B. Issekutz, W. Ruigrok, K. Creaser, G. M. Hirsch, and T. D.G. Lee
Prevention of allograft heart valve failure in a rat model
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 310 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Batten, A. M. McCormack, M. L. Rose, and M. H. Yacoub
Valve interstitial cells induce donor-specific T-cell anergy
J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 129 - 135.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. C. Elkins, P. E. Dawson, S. Goldstein, S. P. Walsh, and K. S. Black
Decellularized human valve allografts
Ann. Thorac. Surg., May 1, 2001; 71 (2007): S428 - S432.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. E. Shaddy, L. M. Lambert, T. C. Fuller, T. Profaizer, D. D. Thompson, S. I. Baker, K. A. Osborne, and J. A. Hawkins
Prospective randomized trial of azathioprine in cryopreserved valved allografts in children
Ann. Thorac. Surg., January 1, 2001; 71(1): 43 - 47.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Forbess, A. S. Shah, J. D. St. Louis, J. J. Jaggers, and R. M. Ungerleider
Cryopreserved homografts in the pulmonary position: determinants of durability
Ann. Thorac. Surg., January 1, 2001; 71(1): 54 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J.-F. Legare, M. A. Nanton, P. Bryan, T. D. G. Lee, and D. B. Ross
Aortic valve graft implantation in rats: a new functional model
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Alexiou, A. McDonald, S. M. Langley, M. J.R. Dalrymple-Hay, M. P. Haw, and J. L. Monro
Aortic valve replacement in children: are mechanical prostheses a good option?
Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 125 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Hawkins, J. P. Breinholt, L. M. Lambert, T. C. Fuller, T. Profaizer, E. C. McGough, and R. E. Shaddy
CLASS I AND CLASS II ANTI-HLA ANTIBODIES AFTER IMPLANTATION OF CRYOPRESERVED ALLOGRAFT MATERIAL IN PEDIATRIC PATIENTS
J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 324 - 330.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Alexiou, S. M. Langley, and J. L. Monro
Surgery for infective valve endocarditis in children
Eur. J. Cardiothorac. Surg., December 1, 1999; 16(6): 653 - 659.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. S. Marino, G. Wernovsky, J. Rychik, J. R. Bockoven, R. I. Godinez, and T. L. Spray
Early Results of the Ross Procedure in Simple and Complex Left Heart Disease
Circulation, November 9, 1999; 100(90002): II-162 - 166.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Osman, J. McCann, R. J. Shemin, and H. L. Lazar
Accelerated allograft degeneration after aortic valve endocarditis
Ann. Thorac. Surg., November 1, 1999; 68(5): 1849 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. K. Najm, J. G. Coles, M. D. Black, L. Benson, and W. G. Williams
EXTENDED AORTIC ROOT REPLACEMENT WITH AORTIC ALLOGRAFTS OR PULMONARY AUTOGRAFTS IN CHILDREN
J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 503 - 509.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W. Daenen, H. Jalali, B. Eyskens, and M. Gewillig
Mid-term results of the Ross procedure
Eur. J. Cardiothorac. Surg., June 1, 1999; 13(6): 673 - 677.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. R. Vogt, T. Stallmach, U. Niederhauser, J. Schneider, G. Zund, M. Lachat, A. Kunzli, and M. I. Turina
Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults
Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. M.E. Hoekstra, M. Witvliet, C. Y. Knoop, C. Wassenaar, A. J.J.C. Bogers, W. Weimar, and F. H.J. Claas
Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies
Ann. Thorac. Surg., December 1, 1998; 66(6): 2022 - 2026.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Rajani, R. B. Mee, and N. B. Ratliff
Evidence for rejection of homograft cardiac valves in infants
J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 111 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Moustapha, D. B. Ross, B. Bittira, D. Van-Velzen, V. C. McAlister, C. L. Lannon, T. D. Lee, and S. D. A. Murphy
AORTIC VALVE GRAFTS IN THE RAT: EVIDENCE FOR REJECTION
J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 891 - 902.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. Chanda, R. Kuribayashi, and T. Abe
Prevention of Calcification in Glutaraldehyde-Treated Porcine Aortic and Pulmonary Valves
Ann. Thorac. Surg., October 1, 1997; 64(4): 1063 - 1066.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti
EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS
J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Chanda, R. Kuribayashi, and T. Abe
NEW-GENERATION VALVED CONDUIT: AN EXPERIMENTAL STUDY
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 218 - 223.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. d. Hamer, B. Hepkema, J. Prop, N. Elzenga, and T. Ebels
HLA ANTIBODIES SPECIFIC FOR CRYOPRESERVED HEART VALVE "HOMOGRAFTS'" IN CHILDREN
J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 417 - 419.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Baskett, D. B. Ross, M. A. Nanton, and D. A. Murphy
FACTORS IN THE EARLY FAILURE OF CRYOPRESERVED HOMOGRAFT PULMONARY VALVES IN CHILDREN: PRESERVED IMMUNOGENICITY?
J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1170 - 1179.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Hogan, L. Duplock, M. Green, S. Smith, K. L. Gall, I. H. Frazer, and M. F. O'Brien
HUMAN AORTIC VALVE ALLOGRAFTS ELICIT A DONOR-SPECIFIC IMMUNE RESPONSE
J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1260 - 1267.
[Abstract] [Full Text]


Home page
CirculationHome page
R. E. Shaddy, D. D. Hunter, K. A. Osborn, L. M. Lambert, L. L. Minich, J. A. Hawkins, E. C. McGough, and T. C. Fuller
Prospective Analysis of HLA Immunogenicity of Cryopreserved Valved Allografts Used in Pediatric Heart Surgery
Circulation, September 1, 1996; 94(5): 1063 - 1067.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Hoekstra, C. Knoop, L. Vaessen, C. Wassenaar, N. Jutte, E. Bos, A. Bogers, and W. Weimar
DONOR-SPECIFIC CELLULAR IMMUNE RESPONSE AGAINST HUMAN CARDIAC VALVE ALLOGRAFTS
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 281 - 286.
[Abstract] [Full Text]


Home page